OncoHost is a technology company that is dedicated to revolutionizing cancer care through personalized medicine. With a mission to translate the predictive power of proteomics into improved patient outcomes, OncoHost aims to overcome the challenge of treatment resistance in clinical oncology. Led by a team of experienced entrepreneurs and industry experts, OncoHost has developed the innovative PROphet® platform.

This platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning to provide clinicians with actionable clinical insights, optimal therapy choices, and a better understanding of a patient's personalized cancer dynamics. Supported by robust clinical evidence, strong intellectual property positioning, and a first-mover advantage, OncoHost's vision is to make a real difference in the lives of cancer patients worldwide. With a large-scale prospective clinical trial underway, OncoHost is at the forefront of oncology beyond the tumor, delivering truly personalized care